Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment

Por Roblyer, Darren, Ueda, Shigeto, Cerussi, Albert, Tanamai, Wendy, Durkin, Amanda, Mehta, Rita, Hsiang, David, Butler, John A., McLaren, Christine, Chen, Wen-Pin, Tromberg, Bruce
Publicado em 2011

Impact of Factors Affecting the Residual Tumor Size Diagnosed by MRI Following Neoadjuvant Chemotherapy in Comparison to Pathology

Por CHEN, JEON-HOR, BAHRI, SHADFAR, MEHTA, RITA S., CARPENTER, PHILIP M., MCLAREN, CHRISTINE E., CHEN, WEN-PIN, FWU, PETER T., HSIANG, DAVID J. B., LANE, KAREN T., BUTLER, JOHN A., SU, MIN-YING
Publicado em 2013

Diagnostic Performance of MRI for Assessing Tumor Response in HER2 Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated with Molecular Biomarker Profile

Por Kuzucan, Aida, Chen, Jeon-Hor, Bahri, Shadfar, Mehta, Rita S., Carpenter, Philip M., Fu, Peter T., Yu, Hon J., Hsiang, David JB, Lane, Karen T., Butler, John A., Feig, Stephen A., Su, Min-Ying
Publicado em 2012

Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging

Por Chen, Jeon-Hor, Bahri, Shadfar, Mehta, Rita S., Kuzucan, Aida, Yu, Hon J., Carpenter, Philip M., Feig, Stephen A., Lin, Muqing, Hsiang, David J. B., Lane, Karen T., Butler, John A., Nalcioglu, Orhan, Su, Min-Ying
Publicado em 2011